<?xml version="1.0" encoding="UTF-8"?>
<p>The human hybridoma technology is a vital tool for production of human monoclonal antibodies. Early on, the possibility of using human mAbs for the prevention or treatment of human diseases was evident and was the driving force behind intensive effort to establish methods for human hybridoma. For this purpose, a selection of techniques could be used with varying efficiencies (Scott and Crowe, 2015).</p>
